Patent · US Active

Method for prevention of colectomy

US9492516B2 · kind B2 · utility

2Cited by

1References

17Claims

0Family size

Assignee

Index Pharmaceuticals AB · SE

Inventors

Charlotte Admyre · Handen, SE
Arezou Zargari · Solna, SE
Oliver Von Stein · Upplands Väsby, SE
Petra Von Stein · Spånga, SE

Key dates

Filing date	Nov 23, 2012
Grant date	Nov 15, 2016
Priority date	—
Expiry date	Nov 23, 2032

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC12N2320/31
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention relates to methods of preventing or reducing the need of colectomy. In particular, the present invention relates to an oligonucleotide, for use in the treatment of an inflammatory bowel disease, such as ulcerative colitis (UC) or Crohn's disease, in a subject that is refractory or responds insufficiently or is intolerant to anti-inflammatory therapy, wherein said oligonucleotide is repetitively administered as a single exposure.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.